Elizabeth Kiracofe, MD, FAAD


Concluding Remarks: Systemic Treatment Considerations for Atopic Dermatitis in Patients of Childbearing Potential

Looking to the future of atopic dermatitis treatment, Drs Kiracofe and Murase offer concluding remarks on current unmet needs, the benefits of treatment guidelines, and the importance of treating itch in patients who are or may become pregnant.

Nathalie Zeitouni, MD, FAAD


Considerations for Hedgehog vs Immunotherapy in Patients with Basal Cell Carcinoma

Experts in dermatology comment on the patient considerations required when deciding on systemic treatment for basal cell carcinoma.

Latanya Benjamin, MD, FAAD, FAAP


Topical Ruxolitinib in Vitiligo: Efficacy, Regional Approvals, and Treatment Strategies in African American Patients

Dr. Latanya Benjamin, MD, FAAD, FAAP, discusses the role of topical ruxolitinib cream in managing vitiligo and its effectiveness in a 25-year-old female patient.

Emma Andrus, Associate Editor


Expert Reflections: Evolution of Patient Interactions

In a milestone year for Dermatology Times, our Editorial Advisory Board reflects on how patient interactions have changed over time.

Killian Meara


Mediterranean Diet and Omega-3 Supplements Shown to Reduce Acne Severity

Adhering to a Mediterranean diet and incorporating omega-3 supplements led to noticeable improvements in acne severity, reducing both inflammatory and non-inflammatory lesions in patients.

Jared Kaltwasser


Post-Acne Vulgaris Scarring Leads to Negative Body Image and Self-Esteem

In a recent study, authors argue that psychosocial impacts should be at the forefront of the discussion in acne scarring, noting that psychopharmacological management may be necessary in instances of severe psychiatric comorbidities.

Klint Peebles, MD


Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.

Neal Bhatia, MD


AAD is More Than Just a Conference

Neal Bhatia, MD, shares his insights on successfully navigating AAD and his session highlights on office politics.

Jared Gollob, MD


KT-474 Demonstrates Efficacy and Promise in Atopic Dermatitis and Hidradenitis Suppurativa Study

Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.

Joseph F. Merola, MD, MMSc


Psoriasis Case Impressions

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.

Elizabeth Arthur, MD


Psychological Effects of Cosmetic Procedures Extend Far Beneath the Surface

Understanding the underlying motivation for seeking out minimally invasive cosmetic procedures is important to provide individualized and holistic care to patients.

Connor Iapoce


Malignancy Risk Low in Secukinumab Treatment

A study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.

Jonathan I Silverberg, MD, PhD, MPH


Don’t Forget to Address Autoimmune Comorbidities of Atopic Dermatitis

Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.

Saranya Wyles, MD, PhD


Strategies for Integrating Advanced Skincare Technologies: Ensuring Evidence-Based Practice

Saranya Wyles, MD, PhD, offers guidance on integrating advanced skincare technologies into their practices and the importance of staying updated through events like the Science of Skincare summit.

Nina Ventura, Correspondent


Harnessing the Potential of Placental Allografts

Placental tissues provide a promising alternative for addressing cutaneous reconstruction while maintaining the most cosmetically pleasing outcome.

Alan Menter, MD


Continuing Medical Education: Three Things to Know About Pustular Psoriasis

Pustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.

Martina Porter, MD


3 Things You Should Know About HS Pathology and Management

Earn CME credit and learn how to optimize a multimodal treatment approach for hidradenitis suppurativa.

Lisa Cristofaro, PharmD, BS, BCACP


The Adalimumab Biosimiliar Pipeline: What's Ahead

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.

Miranda Hester


Amy Paller, MD, Discusses Long-Term Safety and Efficacy of Ixekizumab in Kids

Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.

Muneeb Shah, DO


Muneeb Shah, DO: Behind the Scenes of Launching a Skin Care Brand

Shah discusses the science behind his products, as well as the challenges he didn’t anticipate when launching Remedy.

Sophia Fruechte


Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.

Junqian Zhang, MD


The Importance of Collaboration Between Mohs Surgeons and Urologists

Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.

Julie Harper, MD


Julie Harper, MD, to Present a Rosacea Research Roundup and Pearls

She shares her top 5 considerations for all dermatology drug prescribers.

Jeanine Downie, MD, FAAD


Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, Acne

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.

Amy B. Lewis, MD


Habits, Cultural Norms, and Rapid Advances In Technology Have Dramatically Changed the Aesthetic Medicine Landscape

Amy B. Lewis, MD, explores the evolution of aesthetic dermatology, delving into injection sophistication, devices, and top procedures.

© 2024 MJH Life Sciences

All rights reserved.